Optimal antiplatelet therapy in patients with acute coronary syndrome and chronic kidney disease: for the Jerusalem platelets thrombosis and intervention in cardiology (JUPITER-11) study group

Abstract Introduction Chronic kidney disease (CKD) is a well-documented risk factor for major adverse cardiac events and bleeding events. The optimal antiplatelet strategy for patients with CKD remains unclear, especially patients with glomerular filtration rate (GFR) < 30 ml/min. We aim to compare...

Descripció completa

Dades bibliogràfiques

Autors principals:	Perel Nimrod, Marmor David, Taha Louay, Tabi Meir, Itshak Amsalem, Rafi Hitter, Tomer Maller, Nir Levy, Lior Lupu, Hezzy Shmueli, Sharon Bruoha, Tal Ovdat, Michael Glikson, Elad Asher
Format:	Artigo
Idioma:	Inglês
Publicat:	BMC 2025-08-01
Col·lecció:	BMC Nephrology
Matèries:	Antiplateletu therapy Acute coronary syndrome Chronic kidney disease
Accés en línia:	https://doi.org/10.1186/s12882-025-04227-8
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!